Phase I/II study of the safety of subcutaneous interferon gamma-1b combined with rituximab in patients with low grade/follicular non-Hodgkin's lymphoma
Phase of Trial: Phase I/II
Latest Information Update: 09 Feb 2006
At a glance
- Drugs Interferon gamma-1b; Rituximab
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 23 Sep 2005 New trial record.